Edwards Lifesciences Corporation Capital Expenditures
Edwards Lifesciences Corporation (EW) reported Capital Expenditures of $131.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-04
- Edwards Lifesciences Corporation payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $66.90M, a 35.70% increase year-over-year.
- Edwards Lifesciences Corporation payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $64.90M, a 15.89% increase year-over-year.
- Edwards Lifesciences Corporation payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $97.40M, a 95.58% increase year-over-year.
- Edwards Lifesciences Corporation payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $57.50M, a 10.79% increase year-over-year.
- Edwards Lifesciences Corporation payments to acquire property, plant, and equipment for fiscal 2025 was $260.20M, a 3.09% increase from fiscal 2024.
- Edwards Lifesciences Corporation payments to acquire property, plant, and equipment for fiscal 2024 was $252.40M, a 0.24% decline from fiscal 2023.
- Edwards Lifesciences Corporation payments to acquire property, plant, and equipment for fiscal 2023 was $253.00M, a 3.43% increase from fiscal 2022.
- Edwards Lifesciences Corporation payments to acquire property, plant, and equipment for fiscal 2022 was $244.60M, a 24.92% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $66.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $131.80M 10-Q · filed 2026-08-04 | $229.20M derived: sum of 3 quarters · filed 2026-08-04 | $286.70M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-31 | $64.90M 10-Q · filed 2026-05-06 | $162.30M derived: sum of 2 quarters · filed 2026-05-06 | $219.80M derived: sum of 3 quarters · filed 2026-05-06 | $269.10M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | $97.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $154.90M derived: sum of 2 quarters · filed 2026-02-25 | $204.20M derived: sum of 3 quarters · filed 2026-08-04 | $260.20M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $57.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $106.80M derived: sum of 2 quarters · filed 2026-08-04 | $162.80M 10-Q · filed 2025-11-05 | $212.60M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-30 | $49.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $105.30M 10-Q · filed 2026-08-04 | $155.10M derived: sum of 3 quarters · filed 2026-08-04 | $207.00M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | $56.00M 10-Q · filed 2026-05-06 | $105.80M derived: sum of 2 quarters · filed 2026-05-06 | $157.70M derived: sum of 3 quarters · filed 2026-05-06 | $243.10M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $49.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $101.70M derived: sum of 2 quarters · filed 2026-02-25 | $187.10M derived: sum of 3 quarters · filed 2026-02-25 | $252.40M 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $51.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $137.30M derived: sum of 2 quarters · filed 2025-11-05 | $202.60M 10-Q · filed 2025-11-05 | $290.90M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-06-30 | $85.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $150.70M 10-Q · filed 2025-08-06 | $239.00M derived: sum of 3 quarters · filed 2026-02-25 | $294.30M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-03-31 | $65.30M 10-Q · filed 2025-05-06 | $153.60M derived: sum of 2 quarters · filed 2026-02-25 | $208.90M derived: sum of 3 quarters · filed 2026-02-25 | $256.80M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | $88.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $143.60M derived: sum of 2 quarters · filed 2026-02-25 | $191.50M derived: sum of 3 quarters · filed 2026-02-25 | $253.00M 10-K · filed 2026-02-25 | |||
| 2023-09-30 | $55.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $103.20M derived: sum of 2 quarters · filed 2024-11-06 | $164.70M 10-Q · filed 2024-11-06 | $233.60M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-06-30 | $47.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $109.40M 10-Q · filed 2024-07-31 | $178.30M derived: sum of 3 quarters · filed 2025-02-28 | $238.20M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-03-31 | $61.50M 10-Q · filed 2024-04-29 | $130.40M derived: sum of 2 quarters · filed 2025-02-28 | $190.30M derived: sum of 3 quarters · filed 2025-02-28 | $233.40M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2022-12-31 | $68.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $128.80M derived: sum of 2 quarters · filed 2025-02-28 | $171.90M derived: sum of 3 quarters · filed 2025-02-28 | $244.60M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | $59.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $103.00M derived: sum of 2 quarters · filed 2023-10-27 | $175.70M 10-Q · filed 2023-10-27 | $265.50M derived: sum of 4 quarters · filed 2024-02-12 | |||
| 2022-06-30 | $43.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $115.80M 10-Q · filed 2023-07-28 | $205.60M derived: sum of 3 quarters · filed 2024-02-12 | $266.30M derived: sum of 4 quarters · filed 2024-02-12 | |||
| 2022-03-31 | $72.70M 10-Q · filed 2023-04-28 | $162.50M derived: sum of 2 quarters · filed 2024-02-12 | $223.20M derived: sum of 3 quarters · filed 2024-02-12 | $292.50M derived: sum of 4 quarters · filed 2024-02-12 | |||
| 2021-12-31 | $89.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $150.50M derived: sum of 2 quarters · filed 2024-02-12 | $219.80M derived: sum of 3 quarters · filed 2024-02-12 | $325.80M 10-K · filed 2024-02-12 | |||
| 2021-09-30 | $60.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $130.00M derived: sum of 2 quarters · filed 2022-10-28 | $236.00M 10-Q · filed 2022-10-28 | $349.20M derived: sum of 4 quarters · filed 2023-02-13 | |||
| 2021-06-30 | $69.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $175.30M 10-Q · filed 2022-07-29 | $288.50M derived: sum of 3 quarters · filed 2023-02-13 | $391.80M derived: sum of 4 quarters · filed 2023-02-13 | |||
| 2021-03-31 | $106.00M 10-Q · filed 2022-04-28 | $219.20M derived: sum of 2 quarters · filed 2023-02-13 | $322.50M derived: sum of 3 quarters · filed 2023-02-13 | $430.80M derived: sum of 4 quarters · filed 2023-02-13 | |||
| 2020-12-31 | $113.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $216.50M derived: sum of 2 quarters · filed 2023-02-13 | $324.80M derived: sum of 3 quarters · filed 2023-02-13 | $407.00M 10-K · filed 2023-02-13 | |||
| 2020-09-30 | $103.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $211.60M derived: sum of 2 quarters · filed 2021-10-29 | $293.80M 10-Q · filed 2021-10-29 | $365.30M derived: sum of 4 quarters · filed 2022-02-14 | |||
| 2020-06-30 | $108.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $190.50M 10-Q · filed 2021-07-30 | $262.00M derived: sum of 3 quarters · filed 2022-02-14 | $338.10M derived: sum of 4 quarters · filed 2022-02-14 | |||
| 2020-03-31 | $82.20M 10-Q · filed 2021-04-28 | $153.70M derived: sum of 2 quarters · filed 2022-02-14 | $229.80M derived: sum of 3 quarters · filed 2022-02-14 | $294.40M derived: sum of 4 quarters · filed 2022-02-14 | |||
| 2019-12-31 | $71.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $147.60M derived: sum of 2 quarters · filed 2022-02-14 | $212.20M derived: sum of 3 quarters · filed 2022-02-14 | $254.40M 10-K · filed 2022-02-14 | |||
| 2019-09-30 | $76.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $140.70M derived: sum of 2 quarters · filed 2020-10-26 | $182.90M 10-Q · filed 2020-10-26 | $240.50M derived: sum of 4 quarters · filed 2021-02-12 | |||
| 2019-06-30 | $64.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $106.80M 10-Q · filed 2020-07-27 | $164.40M derived: sum of 3 quarters · filed 2021-02-12 | $249.50M derived: sum of 4 quarters · filed 2021-02-12 | |||
| 2019-03-31 | $42.20M 10-Q · filed 2020-04-28 | $99.80M derived: sum of 2 quarters · filed 2021-02-12 | $184.90M derived: sum of 3 quarters · filed 2021-02-12 | $237.70M derived: sum of 4 quarters · filed 2021-02-12 | |||
| 2018-12-31 | $57.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $142.70M derived: sum of 2 quarters · filed 2021-02-12 | $195.50M derived: sum of 3 quarters · filed 2021-02-12 | $238.70M 10-K · filed 2021-02-12 | |||
| 2018-09-30 | $85.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $137.90M derived: sum of 2 quarters · filed 2019-10-25 | $181.10M 10-Q · filed 2019-10-25 | $233.00M derived: sum of 4 quarters · filed 2020-02-14 | |||
| 2018-06-30 | $52.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $96.00M 10-Q · filed 2019-07-26 | $147.90M derived: sum of 3 quarters · filed 2020-02-14 | $190.20M derived: sum of 4 quarters · filed 2020-02-14 | |||
| 2018-03-31 | $43.20M 10-Q · filed 2019-04-26 | $95.10M derived: sum of 2 quarters · filed 2020-02-14 | $137.40M derived: sum of 3 quarters · filed 2020-02-14 | $195.40M derived: sum of 4 quarters · filed 2020-02-14 | |||
| 2017-12-31 | $51.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $94.20M derived: sum of 2 quarters · filed 2020-02-14 | $152.20M derived: sum of 3 quarters · filed 2020-02-14 | $168.10M 10-K · filed 2020-02-14 | |||
| 2017-09-30 | $42.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $100.30M derived: sum of 2 quarters · filed 2018-10-26 | $116.20M 10-Q · filed 2018-10-26 | $179.40M derived: sum of 4 quarters · filed 2019-02-15 | |||
| 2017-06-30 | $58.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $73.90M 10-Q · filed 2018-07-27 | $137.10M derived: sum of 3 quarters · filed 2019-02-15 | $185.20M derived: sum of 4 quarters · filed 2019-02-15 | |||
| 2017-03-31 | $15.90M 10-Q · filed 2018-04-27 | $79.10M derived: sum of 2 quarters · filed 2019-02-15 | $127.20M derived: sum of 3 quarters · filed 2019-02-15 | $164.30M derived: sum of 4 quarters · filed 2019-02-15 | |||
| 2016-12-31 | $63.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $111.30M derived: sum of 2 quarters · filed 2019-02-15 | $148.40M derived: sum of 3 quarters · filed 2019-02-15 | $176.10M 10-K · filed 2019-02-15 | |||
| 2016-09-30 | $48.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $85.20M derived: sum of 2 quarters · filed 2017-10-27 | $112.90M 10-Q · filed 2017-10-27 | $150.40M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-06-30 | $37.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $64.80M 10-Q · filed 2017-07-28 | $102.30M derived: sum of 3 quarters · filed 2018-02-16 | $128.30M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-03-31 | $27.70M 10-Q · filed 2017-04-28 | $65.20M derived: sum of 2 quarters · filed 2018-02-16 | $91.20M derived: sum of 3 quarters · filed 2018-02-16 | $109.60M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | $37.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $63.50M derived: sum of 2 quarters · filed 2018-02-16 | $81.90M derived: sum of 3 quarters · filed 2018-02-16 | $102.70M 10-K · filed 2018-02-16 | |||
| 2015-09-30 | $26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $44.40M derived: sum of 2 quarters · filed 2016-10-28 | $65.20M 10-Q · filed 2016-10-28 | $99.70M derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2015-06-30 | $18.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $39.20M 10-Q · filed 2016-07-29 | $73.70M derived: sum of 3 quarters · filed 2017-02-17 | $91.80M derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2015-03-31 | $20.80M 10-Q · filed 2016-04-29 | $55.30M derived: sum of 2 quarters · filed 2017-02-17 | $73.40M derived: sum of 3 quarters · filed 2017-02-17 | $89.40M derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2014-12-31 | $34.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $52.60M derived: sum of 2 quarters · filed 2017-02-17 | $68.60M derived: sum of 3 quarters · filed 2017-02-17 | $82.90M 10-K · filed 2017-02-17 | |||
| 2014-09-30 | $18.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $34.10M derived: sum of 2 quarters · filed 2015-10-29 | $48.40M 10-Q · filed 2015-10-29 | $68.50M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-06-30 | $16.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $30.30M 10-Q · filed 2015-07-29 | $50.40M derived: sum of 3 quarters · filed 2016-02-19 | $73.00M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-03-31 | $14.30M 10-Q · filed 2015-04-29 | $34.40M derived: sum of 2 quarters · filed 2016-02-19 | $57.00M derived: sum of 3 quarters · filed 2016-02-19 | $86.50M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2013-12-31 | $20.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $42.70M derived: sum of 2 quarters · filed 2016-02-19 | $72.20M derived: sum of 3 quarters · filed 2016-02-19 | $109.00M 10-K · filed 2016-02-19 | |||
| 2013-09-30 | $22.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $52.10M derived: sum of 2 quarters · filed 2014-10-31 | $88.90M 10-Q · filed 2014-10-31 | $133.00M derived: sum of 4 quarters · filed 2015-02-20 | |||
| 2013-06-30 | $29.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $66.30M 10-Q · filed 2014-08-04 | $51.40M 10-Q · filed 2013-08-06 | $110.40M derived: sum of 3 quarters · filed 2015-02-20 | $136.10M derived: sum of 4 quarters · filed 2015-02-20 | ||
| 2013-03-31 | $36.80M 10-Q · filed 2014-05-02 | $23.00M 10-Q · filed 2013-05-06 | $80.90M derived: sum of 2 quarters · filed 2015-02-20 | $106.60M derived: sum of 3 quarters · filed 2015-02-20 | $127.80M derived: sum of 4 quarters · filed 2015-02-20 | ||
| 2012-12-31 | $44.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $69.80M derived: sum of 2 quarters · filed 2015-02-20 | $91.00M derived: sum of 3 quarters · filed 2015-02-20 | $109.00M 10-K · filed 2015-02-20 | $120.70M 10-K · filed 2013-02-28 | ||
| 2012-09-30 | $25.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $46.90M derived: sum of 2 quarters · filed 2013-11-07 | $64.90M 10-Q · filed 2013-11-07 | $90.90M derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2012-06-30 | $21.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $39.20M 10-Q · filed 2013-08-06 | $65.20M derived: sum of 3 quarters · filed 2014-02-28 | $84.70M derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2012-03-31 | $18.00M 10-Q · filed 2013-05-06 | $44.00M derived: sum of 2 quarters · filed 2014-02-28 | $63.50M derived: sum of 3 quarters · filed 2014-02-28 | $80.70M derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2011-12-31 | $26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $45.50M derived: sum of 2 quarters · filed 2014-02-28 | $62.70M derived: sum of 3 quarters · filed 2014-02-28 | $76.60M 10-K · filed 2014-02-28 | $82.90M 10-K · filed 2012-02-27 | ||
| 2011-09-30 | $19.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $36.70M derived: sum of 2 quarters · filed 2012-11-07 | $50.60M 10-Q · filed 2012-11-07 | $72.30M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-06-30 | $17.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $31.10M 10-Q · filed 2012-08-07 | $52.80M derived: sum of 3 quarters · filed 2013-02-28 | $69.20M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-03-31 | $13.90M 10-Q · filed 2012-05-09 | $35.60M derived: sum of 2 quarters · filed 2013-02-28 | $52.00M derived: sum of 3 quarters · filed 2013-02-28 | $67.70M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2010-12-31 | $21.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $38.10M derived: sum of 2 quarters · filed 2013-02-28 | $53.80M derived: sum of 3 quarters · filed 2013-02-28 | $61.80M 10-K · filed 2013-02-28 | |||
| 2010-09-30 | $16.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $32.10M derived: sum of 2 quarters · filed 2011-11-08 | $40.10M 10-Q · filed 2011-11-08 | $63.80M derived: sum of 4 quarters · filed 2012-02-27 | |||
| 2010-06-30 | $15.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $23.70M 10-Q · filed 2011-08-08 | $47.40M derived: sum of 3 quarters · filed 2012-02-27 | $59.50M derived: sum of 4 quarters · filed 2012-02-27 | |||
| 2010-03-31 | $8.00M 10-Q · filed 2011-05-09 | $31.70M derived: sum of 2 quarters · filed 2012-02-27 | $43.80M derived: sum of 3 quarters · filed 2012-02-27 | ||||
| 2009-12-31 | $23.70M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $35.80M derived: sum of 2 quarters · filed 2012-02-27 | $64.00M 10-K · filed 2012-02-27 | ||||
| 2009-09-30 | $12.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $40.30M 10-Q · filed 2010-11-08 | |||||
| 2009-06-30 | $28.20M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | $50.60M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |